Trends in Hospital Admission for Diabetic Ketoacidosis in Adults With Type 1 and Type 2 Diabetes in England, 1998–2013: A Retrospective Cohort Study
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This study determined trends in hospital admission for diabetic ketoacidosis (DKA) in adults with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) from 1998 to 2013 in England. RESEARCH DESIGN AND METHODS: The study population included 23,246 adults with T1DM and 241,441 adults with T2DM from the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES). All hospital admissions for DKA as the primary diagnosis from 1998 to 2013 were identified. Trends in hospital admission for DKA in incidence, length of hospital stay, 30-day all-cause readmission rate, and 30-day and 1-year all-cause mortality rates were determined using joinpoint regression, negative binomial regression, and logistic regression models. RESULTS: For T1DM, the incidence of hospital admission for DKA increased between 1998 and 2007 and remained static until 2013. The incidence in 2013 was higher than that in 1998 (incidence rate ratio 1.53 [95% CI 1.09–2.16]). For T2DM, the incidence increased 4.24% (2.82–5.69) annually between 1998 and 2013. The length of hospital stay decreased over time for both diabetes types (P ≤ 0.0004). Adults with T1DM were more likely to be discharged within 2 days compared with adults with T2DM (odds ratio [OR] 1.28 [1.07–1.53]). The 30-day readmission rate was higher in T1DM than in T2DM (OR 1.61 [1.04–2.50]) but remained unchanged for both diabetes types over time. Trends in 30-day and 1-year all-cause mortality rates were also stable, with no difference by diabetes type. CONCLUSIONS: In the previous two decades in England, hospitalization for DKA increased in adults with T1DM and in those with T2DM, and associated health care performance did not improve except decreased length of hospital stay.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Over the past decade, rates of these hyperglycemic crises have increased in both type 1 and type 2 diabetes (90,163,164).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [163]
In the citing paper
“Occasionally, people with type 2 diabetes may present with DKA (37,38), particularly members of certain racial and ethnic groups (e.g., African American adults, who may present with ketosis-prone type 2 diabetes) (39).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [37]
In the citing paper
“Occasionally, people with type 2 diabetes may present with DKA (37), particularly members of certain racial, ethnic, and ancestral groups (e.g., African American and Hispanic/Latino adults), who may present with ketosisprone type 2 diabetes (30).”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [37]
In the citing paper
“There has been a concerning rise in the rate of hyperglycemic crises in people with both type 1 diabetes and type 2 diabetes over the past decade (169-171).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [170]
In the citing paper
“these improvements have plateaued in the past decade (170,172,173).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [170]
Citations
Cites
A Modified Poisson Regression Approach to Prospective Studies with Binary Data
Zou, G. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh090 · Cited by 9,615
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
Herrett, E., Gallagher, A. M., Bhaskaran, K., Forbes, H., Mathur, R., van Staa, T., & Smeeth, L. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv098 · Cited by 2,667 · cited 1×
“dates: 1 January 1998, first diabetes visit, patient registration, up to standard date (16), or 18 years old.”
BackgroundHyperglycemic crises in adult patients with diabetes
Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009) · Diabetes Care · doi:10.2337/dc09-9032 · Cited by 2,062
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389 · cited 1×
“Unlike hypoglycemia, which is totally preventable (34), some DKA cases may not have an obvious precipitating”
BackgroundHex, N., Bartlett, C., Wright, D., Taylor, M., & Varley, D. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03698.x · Cited by 819 · cited 1×
“Hospital admission for diabetic ketoacidosis (DKA) is a potentially life-threatening but largely preventable complication in diabetes (1–3) and is associated with significant health care utilization and expenditure (4,5).”
BackgroundMortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes
Laing, S. P., Swerdlow, A. J., Slater, S. D., Burden, A. C., Morris, A., Waugh, N. R., Gatling, W., Bingley, P. J., & Patterson, C. C. (2003) · Diabetologia · doi:10.1007/s00125-003-1116-6 · Cited by 724
Management of Hyperglycemic Crises in Patients With Diabetes
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., Barrett, E. J., Kreisberg, R. A., Malone, J. I., & Wall, B. M. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.131 · Cited by 710 · cited 1×
“trends, the diagnostic criteria ofDKA from the AmericanDiabetes Association in 2001 recommended a classificationof the severity of DKA (mild, moderate, and severe) to help with patient disposition and selection of therapy (30).”
MethodBueno, H. (2010) · JAMA · doi:10.1001/jama.2010.748 · Cited by 710 · cited 1×
“We included two additional variables, length of hospital stay and mortality, that measure quality of care (18,19).”
BackgroundDabelea, D., Rewers, A., Stafford, J. M., Standiford, D. A., Lawrence, J. M., Saydah, S., Imperatore, G., D’Agostino, R. B., Mayer-Davis, E. J., & Pihoker, C. (2014) · Pediatrics · doi:10.1542/peds.2013-2795 · Cited by 417
Self-citation
Research works printed but not linked: 1
- Gallagher, 2011, Linkage of the General Practice Research Database (GPRD) with other data sources, Pharmacoepidemiol Drug Saf, 20, S230
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
“Patients with type 1 diabetes often present with acute symptoms of diabetes and markedly elevated blood glucose levels, and approximately one-third are diagnosed with life-threatening DKA (2).”
BackgroundInfluential2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
“Adults may retain sufficient b-cell function to prevent DKA for many years; such individuals may have remission or decreased insulin needs for months or years and eventually become dependent on insulin for survival and are at risk for DKA (3–5,51,52).”
BackgroundInfluential2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s002 · Cited by 473
Dhatariya, K. K., Glaser, N. S., Codner, E., & Umpierrez, G. E. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0165-1 · Cited by 461
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s006 · Cited by 440
Hyperglycemic crises in adults with diabetes: a consensus report
Umpierrez, G. E., Davis, G. M., ElSayed, N. A., Fadini, G. P., Galindo, R. J., Hirsch, I. B., Klonoff, D. C., McCoy, R. G., Misra, S., Gabbay, R. A., et al. (2024) · Diabetes Care · doi:10.2337/dci24-0032 · Cited by 278
Karslioglu French, E., Donihi, A. C., & Korytkowski, M. T. (2019) · BMJ · doi:10.1136/bmj.l1114 · Cited by 200
Dhatariya, K. K., & Care, T. J. B. D. S. F. I. (2022) · Diabetic Medicine · doi:10.1111/dme.14788 · Cited by 186
Hyperglycaemic crises in adults with diabetes: a consensus report
Umpierrez, G. E., Davis, G. M., ElSayed, N. A., Fadini, G. P., Galindo, R. J., Hirsch, I. B., Klonoff, D. C., McCoy, R. G., Misra, S., Gabbay, R. A., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06183-8 · Cited by 225
“Global reports clearly show an increase in the number of DKA and HHS admissions during the past decade, with recent data reporting a 55% increase in the rate of DKA hospitalisations, especially in adults aged 45 years [4–6].”
InfluentialRoussel, R., Riveline, J.-P., Vicaut, E., de Pouvourville, G., Detournay, B., Emery, C., Levrat-Guillen, F., & Guerci, B. (2021) · Diabetes Care · doi:10.2337/dc20-1690 · Cited by 173
6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026.
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s006 · Cited by 172
Pasquel, F. J., Tsegka, K., Wang, H., Cardona, S., Galindo, R. J., Fayfman, M., Davis, G., Vellanki, P., Migdal, A., Gujral, U., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1168 · Cited by 161
“In-hospital death, n (%) 14 (3) 20 (5) 27 (8) 0.”
BackgroundInfluentialDiabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations
Palermo, N. E., Sadhu, A. R., & McDonnell, M. E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa360 · Cited by 123
“In both the United States and the United Kingdom, DKA hospitalizations have risen sharply in the last decade, despite a decrease in the early part of this century (5, 6).”
BackgroundDiabetes and the COVID-19 pandemic
Khunti, K., Valabhji, J., & Misra, S. (2022) · Diabetologia · doi:10.1007/s00125-022-05833-z · Cited by 141
Benoit, S. R., Hora, I., Pasquel, F. J., Gregg, E. W., Albright, A. L., & Imperatore, G. (2020) · Diabetes Care · doi:10.2337/dc19-2449 · Cited by 117
“(10) found an increase in incidence from1998 to 2007 and then a flattening, whereas for type 2 diabetes, incidence gradually increased at 4.”
BackgroundGoldenberg, R. M., Gilbert, J. D., Hramiak, I. M., Woo, V. C., & Zinman, B. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13811 · Cited by 114
New advances in type 1 diabetes
Subramanian, S., Khan, F., & Hirsch, I. B. (2024) · BMJ · doi:10.1136/bmj-2023-075681 · Cited by 88
Management of diabetic ketoacidosis in adults: A narrative review
Elzouki, A.-N. Y., & Eledrisi, M. S. (2020) · Saudi Journal of Medicine and Medical Sciences · doi:10.4103/sjmms.sjmms_478_19 · Cited by 120
Defining and characterising diabetic ketoacidosis in adults
Dhatariya, K. K. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107797 · Cited by 93
“rates of hospital admission with DKA have risen between 1997 and 2013 [27].”
BackgroundHigh prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care
Goldman, N. R., Fink, D., Cai, J., Lee, Y.-N., & Davies, Z. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108291 · Cited by 84
“[10] Zhong VW, Juhaeri J, Mayer-Davis EJ.”
BackgroundPearson-Stuttard, J., Cheng, Y. J., Bennett, J., Vamos, E. P., Zhou, B., Valabhji, J., Cross, A. J., Ezzati, M., & Gregg, E. W. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00288-6 · Cited by 76
16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s016 · Cited by 80
Increasing Hospitalizations for DKA: A Need for Prevention Programs
Vellanki, P., & Umpierrez, G. E. (2018) · Diabetes Care · doi:10.2337/dci18-0004 · Cited by 78
“(7) in this issue of Diabetes Care examines temporal trends of DKA according to the diagnosis of type 1 and type 2 diabetes between the years 1998 and 2013 in the U.”
BackgroundInfluentialMisra, S., Barron, E., Vamos, E. P., Thomas, S., Dhatariya, K., Kar, P. S., Young, B., Khunti, K., & Valabhji, J. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00208-4 · Cited by 75
Morton, J. I., Lazzarini, P. A., Shaw, J. E., & Magliano, D. J. (2022) · Diabetes Care · doi:10.2337/dc21-2268 · Cited by 74
Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
Gosmanov, A. R., Gosmanova, E. O., & Kitabchi, A. E. (2021) · Cited by 94
Xie, W., Li, Y., Meng, X., & Zhao, M. (2023) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2023.105049 · Cited by 64
Continuous Ketone Monitoring Consensus Report 2021
Nguyen, K. T., Xu, N. Y., Zhang, J. Y., Shang, T., Basu, A., Bergenstal, R. M., Castorino, K., Chen, K. Y., Kerr, D., Koliwad, S. K., et al. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211042656 · Cited by 54
Kao, K., Islam, N., Fox, D. A., & Amed, S. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2020.02.069 · Cited by 52
“1% in adults with type 1 diabetes from 2004 to 2007 in the UK, with rates remaining stably high thereafter; however, DKA was again found to be more common in males than females.(35) These studies had several limitations.”
BackgroundOoi, E., Nash, K., Rengarajan, L. N., Melson, E., Thomas, L., Johnson, A., Zhou, D., Wallett, L., Ghosh, S., Narendran, P., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002451 · Cited by 48
Hampp, C., Swain, R. S., Horgan, C., Dee, E., Qiang, Y., Dutcher, S. K., Petrone, A., Chen Tilney, R., Maro, J. C., & Panozzo, C. A. (2020) · Diabetes Care · doi:10.2337/dc19-1481 · Cited by 47
“085 per 100 person-years among patients with type 2 diabetes (13).”
BackgroundResultAssociation of Type 1 Diabetes and Hypoglycemic and Hyperglycemic Events and Risk of Dementia
Whitmer, R. A., Gilsanz, P., Quesenberry, C. P., Karter, A. J., & LACY, M. E. (2021) · Neurology · doi:10.1212/wnl.0000000000012243 · Cited by 49
“This is crucial to evaluate considering that patients with T1D are more likely to experience severe hypoglycemic events(12,13) and DKA than those with T2D.(14) In addition, these severe glycemic events have been shown to have far-reaching cerebrovascular sequelae.”
BackgroundInfluentialShaka, H., Aguilera, M., Aucar, M. E. L., El‐amir, Z., Wani, F., Muojieje, C. C., & Kichloo, A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab372 · Cited by 42
LACY, M. E., Moran, C., Gilsanz, P., Beeri, M. S., Karter, A. J., & Whitmer, R. A. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002557 · Cited by 42
Kalscheuer, H., Seufert, J., Lanzinger, S., Rosenbauer, J., Karges, W., Bergis, D., Mader, J. K., Zimny, S., Schmid, S. M., Hummel, M., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1160 · Cited by 40
“Therefore, prevention of DKA is one goal in T1DM care, but recent data indicate increased incidence (2).”
BackgroundAlghamdi, N. A., Major, P., Chaudhuri, D., Tsui, J., Brown, B., Self, W. H., Semler, M. W., Ramanan, M., & Rochwerg, B. (2022) · Critical Care Explorations · doi:10.1097/cce.0000000000000613 · Cited by 49
“Although patients with severe DKA often end up being cared for in the ICU, their prognosis is generally good, and their length of stay in ICU short compared with other critically ill patients (2, 34).”
BackgroundNational trends in pediatric admissions for diabetic ketoacidosis, 2006–2016
Everett, E. M., Copeland, T. P., Moin, T., & Wisk, L. E. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab287 · Cited by 38
Thammakosol, K., & Sriphrapradang, C. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14929 · Cited by 38
Garrett, C. J., Choudhary, P., Amiel, S. A., Fonagy, P., & Ismail, K. (2019) · Diabetic Medicine · doi:10.1111/dme.14109 · Cited by 37
Hurtado, C. R., Lemor, A., Vallejo, F., Lopez, K., Garcia, R., Mathew, J., & Galindo, R. J. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0457 · Cited by 33
Clinical characteristics of diabetic ketoacidosis in users and non-users of SGLT2 inhibitors
Jeon, J. Y., Kim, S.-K., Kim, K.-S., Song, S. O., Yun, J., Kim, B.-Y., Kim, C.-H., Park, S. O., Hong, S., Seo, D. H., et al. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.01.001 · Cited by 34
Charoenpiriya, A., Chailurkit, L., & Ongphiphadhanakul, B. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00922-3 · Cited by 33
“In western countries, during the last two decades, hospitalizations for DKA at least in England have increased for both adult patients with type 1 diabetes and adult patients with type 2 diabetes [21].”
BackgroundA systematic literature review on the burden of diabetic ketoacidosis in type 2 diabetes mellitus
Wysham, C., Bindal, A., Levrat‐Guillen, F., Kostadinova, D., & Poon, Y. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16282 · Cited by 35
Thewjitcharoen, Y., Plianpan, P., Chotjirat, A., Nakasatien, S., Chotwanvirat, P., Wanothayaroj, E., Krittiyawong, S., & Himathongkam, T. (2019) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2019.100188 · Cited by 36
Thomas, M., Harjutsalo, V., Feodoroff, M., Forsblom, C., Gordin, D., & Groop, P.-H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz003 · Cited by 30
Sato, Y., Morita, K., Okada, A., Matsui, H., Fushimi, K., & Yasunaga, H. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108588 · Cited by 31
Darmawan, E. S., Permanasari, V. Y., Nisrina, L. V., Kusuma, D., Hasibuan, S. R., & Widyasanti, N. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21050581 · Cited by 30
“However, the duration of hospitalization has decreased [21].”
BackgroundCharleer, S., De Block, C., Radermecker, R., Weber, E., Vercammen, C., Strivay, M., Scarniere, D., Taes, Y., Spincemaille, K., LOWYCK, I., et al. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.2525.abstracts · Cited by 29
Clinical characteristics and outcomes of care in patients hospitalized with diabetic ketoacidosis
Eledrisi, M. S., ALKABBANI, H. M., ABOAWON, M. K., Ali, A., Alabdulrazzak, I., Elhaj, M. F., Ahmed, A., Alqahwachi, H., Daghfal, J., Beshyah, S., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110041 · Cited by 33
Li, L., Andrews, E. B., Li, X., Doder, Z., Zalmover, E., Sharma, K., Oliveira, J. H., Juhaeri, J., & Wu, C. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107932 · Cited by 27
Self-citationEuglycemic ketoacidosis induced by therapeutic fasting in a non-diabetic patient
Larroumet, A., Camoin, M., Foussard, N., Alexandre, L., Mesli, S., Redonnet‐Vernhet, I., Baillet‐Blanco, L., Rigalleau, V., & Mohammedi, K. (2019) · Nutrition · doi:10.1016/j.nut.2019.110668 · Cited by 26
O’Reilly, J. E., Jeyam, A., Caparrotta, T. M., Mellor, J., Hohn, A., McKeigue, P. M., McGurnaghan, S. J., Blackbourn, L. A. K., McCrimmon, R., Wild, S. H., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0689 · Cited by 25
“Increases in DKA admission rates have been identified in England, Wales, Australia and New Zealand, Denmark, and the United States (21–25), although reductions in DKA admission rates have been observed in Italy and Taiwan (26,27).”
Management of diabetic ketoacidosis in special populations
Eledrisi, M. S., Beshyah, S., & Malik, R. A. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108744 · Cited by 27
Horii, T., Oikawa, Y., Atsuda, K., & Shimada, A. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13506 · Cited by 23
Gorchane, A., Ach, T., Sahli, J., Abdelkrim, A. B., Mallouli, M., Bellazreg, F., Hachfi, W., Chaieb, M. C., & Koussay, A. C. H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1234256 · Cited by 23
Ibrahim, A., Bayramoğlu, B., Hökenek, N. M., & Tekyol, D. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14204 · Cited by 22
AbuHammad, G. A. R., Naser, A. Y., & Hassouneh, L. K. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01352-z · Cited by 22
“A previous retrospective cohort study in England showed a high rate of hospital admissions related to type I diabetes mellitus with ketoacidosis between 1998 and 2007 [41].”
BackgroundInfluentialAllcock, B., Stewart, R., & Jackson, M. C. (2021) · Diabetic Medicine · doi:10.1111/dme.14663 · Cited by 21
“Small sample Everett & Mathioudakis (2019)33US Cross- sectional database review n = 4037 T1D 2– 80+ years (precise upper limit unspecified) 1931 (f), 2106 (m) >1 diabetic ketoacidosis readmission during the study period across (5 years) Repeat diabetic ketoacidosis more likely in women in both paediatric and adult gro…”
BackgroundInfluentialLiu, W., Shi, J., He, S., Luo, X., Zhong, W., & Yang, F. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248157 · Cited by 23
Biester, T., Schwandt, A., Heidtmann, B., Rami-Merhar, B. M., Haak, T., Festa, A., Kostow, S., Müller, A., Mönkemöller, K., Danne, T., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0675 · Cited by 21
Diabetic ketoacidosis risk during the COVID-19 pandemic
Vellanki, P., & Umpierrez, G. E. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00241-2 · Cited by 20
Almazrouei, R. A., Afandi, B. O., AlKindi, F., Govender, R. D., & Al-Shamsi, S. (2023) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514231153717 · Cited by 24
An Improved Ensemble Method for Predicting Hyperchloremia in Adults With Diabetic Ketoacidosis
Obaido, G., Ogbuokiri, B., Chukwu, C. W., Osaye, F. J., Egbelowo, O. F., Uzochukwu, M. I., Mienye, I. D., Aruleba, K., Primus, M., & Achilonu, O. (2024) · IEEE Access · doi:10.1109/access.2024.3351188 · Cited by 21
Ata, F., Khan, A. A., Khamees, I., Mohammed, B. Z. M., Barjas, H., Muthanna, B., Bashir, M., & Kartha, A. B. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01446-8 · Cited by 19
“The most elaborative results come from the study conducted by Zhong et al., which comprised more than 4000 DKA admissions from 1998 to 2013 [13], showing an annual increase of 4.2% in the incidence of DKA in patients with T2D.”
BackgroundResultInfluentialGalindo, R. J., Pasquel, F. J., Vellanki, P., Zambrano, C., Albury, B., Perez-Guzman, C., Ziduo, Z., & Umpierrez, G. E. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab126 · Cited by 17
SGLT Inhibitors for Type 1 Diabetes: An Obvious Choice or Too Good to Be True?
Riddle, M. C., & Cefalu, W. T. (2018) · Diabetes Care · doi:10.2337/dci18-0041 · Cited by 18
“also true for patients thought to have T2D who actually have T1D and are already being prescribed SGLTi, especially given recent reports of increasingly frequent hospital admissions for DKA generally (22,23).”
BackgroundThe psychopathology of recurrent diabetic ketoacidosis: A case–control study
Garrett, C. J., Moulton, C. D., Choudhary, P., Amiel, S. A., Fonagy, P., & Ismail, K. (2020) · Diabetic Medicine · doi:10.1111/dme.14505 · Cited by 18
Kleiner, A., Cum, B., Pisciotta, L., Cincione, R. I., Cogorno, L., Prigione, A., Tramacere, A., Vignati, A., Carmisciano, L., & Sukkar, S. G. (2022) · Nutrients · doi:10.3390/nu14153208 · Cited by 17
“These complications represent one of the leading causes of hospitalization [14,15] with high related social costs [16], and unfortunately, even today, they remain one of the possible causes of death for young and older adults with diabetes, for both type 1 and type 2 [17,18].”
BackgroundScheuer, S. H., Andersen, G. S., Carstensen, B., Díaz, L. J., Kosjerina, V., Lindekilde, N., Wild, S. H., Jackson, C., Pouwer, F., Benros, M. E., et al. (2024) · Diabetes Care · doi:10.2337/dc23-2394 · Cited by 16
Sırakaya, H. A., Sipahioğlu, H., Çetinkaya, A., & Aydın, K. (2025) · Medicina · doi:10.3390/medicina61020321 · Cited by 14
“Recent studies have reported a global increase in hospital admissions due to DKA in both type 1 and type 2 DM patients [1].”
Schwartz, D. D., Banuelos, R. C., Uysal, S., Vakharia, M., Hendrix, K. R., Fegan‐Bohm, K., Lyons, S. K., Sonabend, R., Gunn, S., & Dei-Tutu, S. A. (2022) · Clinical Diabetes · doi:10.2337/cd21-0070 · Cited by 15
Yeo, S. M., Park, H., Paek, J. H., Park, W. Y., Han, S., Park, S. B., & Jin, K. (2019) · Medicine · doi:10.1097/md.0000000000014150 · Cited by 14
“Patients with DM usually experience DKA.”
BackgroundBhatt, P. J., Dave, M., Amponsah, J. K., Jain, A., Yagnik, P. J., Asare‐Afriyie, B., Donda, K., Sharma, M., Parmar, N. G., Patel, A., et al. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13059 · Cited by 14
Monteiro, L. E. D. R. C., Garcia, S. P., Bottino, L. G., Custódio, J. L., Teló, G. H., & Schaan, B. D. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000480 · Cited by 14
“Its prevalence has increased over the past two decades, with approximately 50 to 100 events per 1,000 adult patients with type 1 diabetes (1-3).”
BackgroundAlmazrouei, R., Siddiqua, A., Alnuaimi, M., Al-Shamsi, S., & Govender, R. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.918253 · Cited by 11
“These findings are supported by other studies (5, 12), whereas results from Saudi Arabia (a country within the MENA region) tended to be much lower at”
ResultElsherif, I., Jammah, A. A., Ibrahim, A. R., Alawadi, F., Sadek, I. S., Rahman, A. M., Sharify, G. E., AlFeky, A., Aldossari, K. K., Roushdy, E., et al. (2024) · Primary care diabetes · doi:10.1016/j.pcd.2024.06.003 · Cited by 11
Babar, B., & Aamir, A. H. (2022) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.38.5.5227 · Cited by 11
“Less than a year 3 (27) 6 (55) 2 (18) 11 (11)”
Agarwal, M. A., Jain, N., Podila, P. S. B., Varadarajan, V., Patel, B. D., Shah, M. K., Garg, L., Khouzam, R. N., Ibebuogu, U. N., Reed, G. L., et al. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.107466 · Cited by 11
Thakare, P. S., & Ankar, R. S. (2021) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2021/298 · Cited by 10
PROFILE OF DIABETIC KETOACIDOSIS PATIENTS AT REGIONAL PUBLIC HOSPITAL DR. SOETOMO IN 2017
Dewata, D. G. U. B., Novida, H., & Aryati, A. (2020) · Jurnal Berkala Epidemiologi · doi:10.20473/jbe.v8i32020.301-309 · Cited by 9
dos Santos, S. S., Ramaldes, L. A., Dualib, P. M., Gabbay, M. A. L., de Sá, J. R., & Dib, S. A. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01054-5 · Cited by 9
“Questionably, even with the low mortality rate (1–2%) in acute events [1, 8, 9], mainly justified by guidelines and institutional protocols to diagnose and treat this condition and avoid unfavorable outcomes, evidence reveals that recurrent DKA (rDKA) throughout the life of a patient with T1D can be an important predi…”
BackgroundDu, S., Zhang, H., Wu, H., Ye, S., Wen, L., & Su, Q. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s252492 · Cited by 9
Masuda, S., Ota, K., Okazaki, R., Ishii, R., Cho, K., Hiramatsu, Y., Adachi, Y., Koseki, S., Ueda, E., Minami, I., et al. (2022) · Internal Medicine · doi:10.2169/internalmedicine.7266-21 · Cited by 9
“Given that DKA is potentially life-threatening but largely preventable (3), analyzing the clinical and biochemical features associated with DKA may have significant implications on the patient care and healthcare expenditure.”
BackgroundGómez, P. R. D. V., Jiménez, B. R., Sánchez, E. M., Sánchez, F. J., García, R. R., Umpierrez, G. E., & Martínez‐Brocca, M. A. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112372 · Cited by 8
Munsakul, N., Manosroi, W., & Buranapin, S. (2024) · Medicina · doi:10.3390/medicina60111833 · Cited by 9
Li, A., Jiang, X., Zhong, M., Li, N., Tao, Y., Wu, W., Yang, C., Wang, H., Min, L., Ma, Y., et al. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820934307 · Cited by 10
Blank, S. P., Blank, R. M., & Campbell, L. T. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.06.001 · Cited by 8
Alsaif, M., Farhat, A. A. K., Blumer, Z., & Barham, L. (2024) · Health Economics Review · doi:10.1186/s13561-024-00505-7 · Cited by 7
Trends in diabetic ketoacidosis in Victoria, Australia 2002–2016
Jones, H. C., Kiburg, K., Lee, M. H., O'Neal, D. N., & MacIsaac, R. J. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01650-0 · Cited by 7
“In the United Kingdom (UK), one in five DKA admissions are reported to occur in patients with T2D [3].”
BackgroundInfluentialSebastián‐Valles, F., Tapia-Sanchiz, M. S., Navas-Moreno, V., Lopez-Ruano, M., Martínez-Otero, C., Carrillo-López, E., Ganga, C. S. L., Raposo‐López, J. J., Amar, S., Castañar, S. G., et al. (2024) · Internal and Emergency Medicine · doi:10.1007/s11739-024-03813-2 · Cited by 7
Eckert, A. J., Mader, J. K., Altmeier, M., Mühldorfer, S., Gillessen, A., Dallmeier, D., Shah, V. N., Heyer, C. H. J., Hartmann, B., & Holl, R. W. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107664 · Cited by 7
Etiologies and Outcomes of Diabetic Ketoacidosis in Cancer Patients: A Retrospective Analysis
Gandhi, A., Jeun, R., Wang, Z., Khan, S., Best, C. J., Lavis, V. R., & Thosani, S. (2025) · Cancers · doi:10.3390/cancers17172728 · Cited by 6
“Previous studies in non-cancer cohorts report median hospital stays of about 2–3 days for DKA [28,29].”
Feky, A. Y. E., Abdou, M. S. M., Naguib, R., Abdelsalam, S. F., Hamdy, M., & Elrahmany, S. M. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.08.006 · Cited by 6
Thammakosol, K., Jantarapootirat, M., Traiwanatham, S., & Sriphrapradang, C. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70101 · Cited by 6
“One possible explanation for this delayed effect, compared to the more rapid response seen in the glargine U-100 trial, is that insulin degludec reaches steady-state levels around days 3 – 4 after initiation.”
SGLT-2 inhibitor associated euglycaemic diabetic ketoacidosis in an orthopaedic trauma patient
Ritchie, D. T., & Dixon, J. E. (2022) · BMJ Case Reports · doi:10.1136/bcr-2022-250233 · Cited by 6
Epidemiology and Public Health
Mayer‐Davis, E. J., & IGUDESMAN, D. A. (2022) · doi:10.1093/med/9780198870197.003.0243 · Cited by 6
Self-citation
Metadata
- Authors
- Zhong, V. W., Juhaeri, J., & Mayer-Davis, E. J.
- Affiliations
- Northwestern University (US)
- Sanofi (United States) (US)
- Department of Nutrition, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-01-31
- Volume
- 41
- Issue
- 9
- Pages
- 1870-1877
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2792754396
- Semantic Scholar
- acbda12890c5a3490c6042ae825f68c568de1957
- Cited by
- 177
- References
- 34
- Citations by year
- 2026: 14 · 2025: 26 · 2024: 26 · 2023: 17 · 2022: 25 · 2021: 27 · 2020: 17 · 2019: 19 · 2018: 6
- FWCI
- 13.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sanofi Global Nutrition Scholars program at the University of North Carolina at Chapel Hill
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- diabetic ketoacidosis, hospital admission trends, type 1 diabetes, type 2 diabetes, length of hospital stay, hospital readmission, all-cause mortality, incidence, England
- MeSH terms
- Adult, Aged, Aged, 80 and over, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, England, Female, Hospitalization, Humans, Length of Stay, Male, Middle Aged, Patient Admission, Patient Discharge, Patient Readmission, Retrospective Studies, Incidence, Diabetic Ketoacidosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.